Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients
- 25 April 2005
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 24 (33), 5258-5261
- https://doi.org/10.1038/sj.onc.1208702
Abstract
The aim of this study was to investigate the level and the prognostic value of the expression of different survivin transcript variants--survivin, survivin-DeltaEx3 and survivin-2B--in tumours of 76 soft tissue sarcoma (STS) patients. The expression of survivin transcript variants in STS tissue samples and in 12 nonmalignant control tissues was analysed by quantitative RT-PCRs. Expression levels of all survivin transcript variants were strongly elevated in STS compared to normal tissues. A positive correlation between expression of splice variants and tumour stage was found (P=0.02; chi2 test). The multivariate Cox's proportional hazards regression model revealed a 7.3-fold increased risk of tumour-related death for patients with survivin-DeltaEx3 overexpressing tumours (P=0.007). The effect of surivivin (wildtype variant) and survivin-2B was less pronounced but still significant (2.2- and 1.9-fold, resp., P<0.05 each). Our results show for the first time that mRNA expression of survivin-variants is significantly correlated to a poor prognosis for STS patients, and we suggest expression of survivin splice variants together with tumour stage as independent predictor of survival.Keywords
This publication has 15 references indexed in Scilit:
- Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcomeBritish Journal of Cancer, 2005
- Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancerBritish Journal of Cancer, 2004
- Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemiaLeukemia Research, 2004
- Lack of prognostic significance of survivin, survivin-ΔEx3, survivin-2B, galectin-3, bag-1, bax-α and MRP-1 mRNAs in breast cancerCancer Letters, 2003
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Survivin study: What is the next wave?Journal of Cellular Physiology, 2003
- Differential subcellular localization of functionally divergent survivin splice variantsCell Death & Differentiation, 2002
- Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomasInternational Journal of Cancer, 2002
- Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcomaThe Lancet, 2002
- High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastomaOncogene, 2000